On market sale of Ordinary Shares and immediate purchase by way of Bed and SIPP arrangement of 237 shares
Helios Underwriting Plc
30 September 2026
30 September 2026
Helios Underwriting plc
("Helios" or the "Company")
Director/PDMR Shareholding
Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, the world's largest insurance market, was informedon 29 September 2026 that Mr John Chambers, Non-Executive Chairman and Director of the Company, on the same day, sold 150,000 ordinary shares of 10 pence each ("Ordinary Shares") at a price of 237.5 pence per share through Fairburn Continuation Limited, a person closely associated with Mr Chambers, and subsequently purchased 150,000 Ordinary Shares at a price of 237.5 pence per share into his Self-Invested Personal Pension ("SIPP"), in order to effect a “Bed and SIPP” trade. Mr Chambers’ and persons closely associated with Mr Chambers’ total interest remains unchanged at 600,000 Ordinary Shares, representing 0.9% of voting rights of the Company.
The notification below, which has been made in accordance with the requirement of the UK Market Abuse Regulation, provides further details.
For further information, please contact:
Helios Underwriting plc
Louis Tucker - Chief Executive Officer+44 (0)203 965 6441
Adhiraj Maitra – Director of Finance and Operations+44 (0)203 743 2114
Peel Hunt (Nomad, Broker and Financial Adviser)
Dan Webster / Andrew Buchanan / Martin Frowde +44 (0)20 7418 8900
Singer Capital Markets (Joint Broker)
Charles Leigh-Pemberton / Russell Cook / James Todd +44 (0)20 7496 3000
FTI Consulting
Ed Berry +44 (0)7703 330 199
Christian Harte +44 (0)7974 288 763
About Helios
Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||
|
a) |
Name
|
John Chambers (Director) Fairburn Continuation Limited (PCA) |
||||||||
|
2 |
Reason for the notification |
|||||||||
|
|
|
Director PCA |
||||||||
|
b) |
Initial notification/Amendment
|
Initial Notification |
||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
|
a) |
Name |
Helios Underwriting Plc |
||||||||
|
b) |
LEI |
213800FX86DJW5TCM864 |
||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
|
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of 10 pence each
ISIN - GB00B23XLS45 |
||||||||
|
b) |
Nature of the transaction
|
On market sale of Ordinary Shares and immediate purchase by way of Bed and SIPP arrangement |
||||||||
|
c) |
Price(s) and volume(s)
|
|
||||||||
|
d) |
Aggregated information
|
|
||||||||
|
e) |
Date of the transaction |
29 September 2026 |
||||||||
|
f) |
Place of the transaction
|
London Stock Exchange, AIM |
||||||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.